Caroline Baumal, the Chief Medical Officer of $APLS, sold 1,882 shares of the company on 01-20-2026 for an estimated $37,250. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.1% of their shares of this class of stock. Following this trade, they now own 89,324 shares of this class of $APLS stock.
$APLS Insider Trading Activity
$APLS insiders have traded $APLS stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $APLS stock by insiders over the last 6 months:
- CEDRIC FRANCOIS (Chief Executive Officer) has made 0 purchases and 4 sales selling 243,368 shares for an estimated $6,740,686.
- TIMOTHY EUGENE SULLIVAN (Chief Financial Officer) has made 0 purchases and 5 sales selling 59,477 shares for an estimated $1,613,224.
- A. SINCLAIR DUNLOP has made 0 purchases and 2 sales selling 62,184 shares for an estimated $1,451,097.
- DAVID O. WATSON (General Counsel) has made 0 purchases and 8 sales selling 53,255 shares for an estimated $1,310,179.
- CAROLINE BAUMAL (Chief Medical Officer) has made 0 purchases and 2 sales selling 4,902 shares for an estimated $114,346.
- NUR NICHOLSON (Chief Technical Officer) has made 0 purchases and 2 sales selling 4,821 shares for an estimated $101,689.
- PASCAL DESCHATELETS (Chief Scientific Officer) has made 0 purchases and 2 sales selling 3,186 shares for an estimated $68,512.
- MARK JEFFREY DELONG (Chief Business & Strat Officer) has made 0 purchases and 2 sales selling 3,114 shares for an estimated $65,896.
- JAMES GEORGE CHOPAS (VP/Chief Accounting Officer) has made 0 purchases and 4 sales selling 2,336 shares for an estimated $53,697.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APLS Hedge Fund Activity
We have seen 150 institutional investors add shares of $APLS stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC removed 8,448,652 shares (-71.0%) from their portfolio in Q3 2025, for an estimated $191,192,994
- MARSHALL WACE, LLP removed 2,308,102 shares (-85.3%) from their portfolio in Q3 2025, for an estimated $52,232,348
- JENNISON ASSOCIATES LLC added 1,686,232 shares (+63.3%) to their portfolio in Q3 2025, for an estimated $38,159,430
- AQR CAPITAL MANAGEMENT LLC removed 1,489,060 shares (-24.9%) from their portfolio in Q3 2025, for an estimated $33,697,427
- UBS GROUP AG removed 1,305,406 shares (-27.6%) from their portfolio in Q3 2025, for an estimated $29,541,337
- POLAR CAPITAL HOLDINGS PLC added 1,298,055 shares (+96.0%) to their portfolio in Q3 2025, for an estimated $29,374,984
- MILLENNIUM MANAGEMENT LLC added 1,141,274 shares (+563.7%) to their portfolio in Q3 2025, for an estimated $25,827,030
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$APLS Analyst Ratings
Wall Street analysts have issued reports on $APLS in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 01/13/2026
- Stifel issued a "Buy" rating on 12/19/2025
- JP Morgan issued a "Overweight" rating on 11/05/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/31/2025
- Citigroup issued a "Buy" rating on 10/31/2025
- TD Cowen issued a "Buy" rating on 10/31/2025
- Wells Fargo issued a "Overweight" rating on 10/15/2025
To track analyst ratings and price targets for $APLS, check out Quiver Quantitative's $APLS forecast page.
$APLS Price Targets
Multiple analysts have issued price targets for $APLS recently. We have seen 14 analysts offer price targets for $APLS in the last 6 months, with a median target of $35.5.
Here are some recent targets:
- Tazeen Ahmad from B of A Securities set a target price of $28.0 on 01/21/2026
- Derek Archila from Wells Fargo set a target price of $26.0 on 01/20/2026
- Steve Seedhouse from Cantor Fitzgerald set a target price of $35.0 on 01/13/2026
- Joseph Stringer from Needham set a target price of $28.0 on 01/13/2026
- Annabel Samimy from Stifel set a target price of $48.0 on 12/19/2025
- Anupam Rama from JP Morgan set a target price of $36.0 on 11/05/2025
- Graig Suvannavejh from Mizuho set a target price of $19.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
